Sismanogleio General Hospital — Clinical Trial Site

10 Registered trials

6 Currently recruiting

Organisation

Sismanogleio General Hospital

Location

Maroussi, Greece

Identifier

ORG-100031833

Address

Sismanogliou 37, 151 26, Greece

Departments

1st Department of Internal Medicine
2nd Department of Internal Medicine
2nd University Urology Clinic
Adult CF Unit
Cardiology Department
Cardiology department & Intensive Cardiac Care Unit
Hemodynamic Department
Intensive Care Unit
Opthalmology Clinic

Clinical trials at this site (10)

Search interface

HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
A trial to learn how well AZD0292 works, how safe it is, and how it moves throughout the body over time in people with bronchiectasis and ch… Recruiting

2025-523009-14-00 Bronchiectasis with chronic pseudomonas aeruginosa colo 4 2025-12-16
A Phase 3, Randomized, Open-label, Multicenter Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System … Recruiting

2024-519493-39-00 High-risk Non-muscle-invasive Bladder Cancer with Susce 5 2025-12-09
Biomarker-Guided Early Clarithromycin Treatment To Prevent Sepsis Progression In Community-Acquired Pneumonia: The REACT Randomized Clinical… Recruiting

2023-507295-40-00 Community-acquired pneumonia 5 2024-02-12
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
EMAPALUMAB TREATMENT FOR ANTICIPATED CLINICAL BENEFIT IN SEPSIS DRIVEN BY THE INTERFERON-GAMMA ENDOTYPE (THE EMBRACE TRIAL) Ended

2024-515255-38-00 SEPSIS 4 2025-03-12
ARTEMIS - A research study to look at how ziltivekimab works compared to placebo in people who have had a heart attack Ended

2023-506876-28-00 The medical condition we are investigating is type 1 AM 5 2024-08-01
ATHENA: A research study looking into how ziltivekimab works compared to placebo in people with heart failure and inflammation Ended

2023-506988-34-00 Heart failure with mildly reduced or preserved ejection 5 2024-03-27
A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE IN… Ended

2022-502962-26-00 Severe infections 5 2023-09-14
A Study for Comparing a Generic Combination of Brinzolamide and Timolol Eye Drops versus Azarga® Eye Drops in the Treatment of Patients with… Ended

2023-506494-35-00 Ocular Hypertension 5 2024-07-15